Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

ProstateCancer.me Launched to Address Issues Identified in the First Prostate Cancer Patient Survey
  • Middle East - English

Prostatecancer.me, the region's first dedicated platform is launched to inform, educate and address patients' needs

Results from Egypt's first prostate cancer patient survey announced

Only 7% of Egypt's men feel well informed on the disease vs 77% in Europe[1]


News provided by

Astellas Pharma Inc.

Oct 02, 2019, 05:52 ET

Share this article

Share toX

Share this article

Share toX

CAIRO, Oct. 2, 2019 /PRNewswire/ -- Advocacy League, CanSurvive, Egyptian Urology Association and Astellas Pharma Inc. today proudly announced the results and insights gained from 'Every Voice Matters' market research conducted with prostate cancer patients and the launch of ProstateCancer.me – first prostate cancer awareness portal in Arabic language, that is addressing some of the identified patients' needs from the research.   

To view the Multimedia News Release, please click: https://www.multivu.com/players/uk/8617451-prostate-cancer-me-launched/ 

Continue Reading
EveryVoiceMatters Results and ProstateCancer.me launch
EveryVoiceMatters Results and ProstateCancer.me launch

"We are very proud to launch ProstateCancer.me, the first patient centric prostate cancer awareness website in our local Arabic language. We hope that having access to information about prostate cancer, disease treatment options, possible lifestyle modifications, as well as advice for the carers will have a positive impact on the patients and their families" said Prof. Mohsen Mokhtar, Founder of Advocacy League.

Access to information about prostate cancer in local language is necessary for several reasons. Prostate cancer prevalence is estimated to continue to increase across the region[2]. It is estimated that by 2030 prostate cancer incidence will increase by 128% in Saudi Arabia and Lebanon will experience the most modest (38%) incidence increase in the region [2] .

Most men with prostate cancer will not experience any symptoms in early disease stages[3], hence being aware of the disease symptoms and risk factors, could encourage men to be more proactive in managing their health. According to the results of Every Voice Matters survey with Egyptian prostate cancer patients, 78% of participants have visited their doctor because they were experiencing symptoms vs 32% in Europe[1]. This is highly concerning, as cancer that is detected early is much easier to treat[4].  

Currently prostate cancer patients and their families have very limited amount of information about the prostate cancer, only 7% of survey participants stated that they feel well informed about the disease (vs 77% in Europe)[1]. Prostate Cancer patient Mr. Maan Tawachi shared his story of fighting prostate cancer and reflected on the importance of having access to information "Having the necessary information at my disposal was immensely helpful as I was able to understand how to better manage disease symptoms and treatment side effects. It empowered me to be more involved in the disease management discussions with different doctors who were involved throughout my treatment."

ProstateCancer.me portal provides information about the regional prevalence of prostate cancer, disease symptoms and risk factors, methods for disease detection and diagnosis, healthcare team involved in prostate cancer treatment and their responsibilities, disease staging and available treatment options, suggestions of questions to ask the treating doctor, tips for lifestyle management (diet and exercise) and information specifically for the family and/ or the caregiver.

"We have worked with patient organizations across the region to ensure that ProstateCancer.me provides trusted and reliable information to support all prostate cancer patients and their families." Prof. Mohsen Mokhtar, Founder of Advocacy League. The website is endorsed by patient organizations from across the region: CanSurvive (Egypt), Barbara Nassar (Lebanon), Friends of Cancer Patients (United Arab Emirate), National Cancer Control Foundation (Yemen); Al-Sidra Association (Kuwait) and Shifa for Supporting Cancer Patients (Morocco).

Astellas Pharma is the sponsor of both Every Voice Matters and ProstateCancer.me. Amr Seif, General Manager for MENA/SSA commented on the launch of both initiatives: "Patient centricity is at the core of our business. We are proud to sponsor ProstateCancer.me and Every Voice Matters to address the lack of access to information for patients in the Middle East and listen to their specific needs. We are committed in our continued support to patient organizations and medical societies across the region, in order to address the needs of the patients."  

About Every Voice Matters

Every Voice Matters is a MENA wide initiative that aims to give prostate cancer patients a voice, so that their needs are heard and understood. The initiative is sponsored by Astellas Pharma Inc. and endorsed by medical societies and patient organizations from across the region including CanSurvive (Egypt), Egyptian Urology Association, Emirates Urology Society (UAE), Friends of Cancer patients (UAE), Saudi Cancer Foundation (KSA), Saudi Urology Association (KSA), Lebanese Medical Oncology Society, Lebanese Urology Society, and Barbara Nassar (Lebanon). The research was conducted by the independent research agency, IPSOS.

About ProstateCancer.me  

ProstateCancer.me is the first regional prostate cancer portal in Arabic language that provides information about the disease and empowers patients and their family/caregivers with needed information. The website is created and managed by Arab Advocacy league working, who are in partnership with other patient organizations across the MENA region.  For more information please visit, www.prostatecancer.me 

About Astellas

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, please visit our website at https://www.astellas.com/en and www.astellasmenassa.com.

About Advocacy League  

Advocacy League is a non-profit organization that constitutes of 16 cancer patients' groups and organizations across the MENA region. The organization is committed to fight cancer across the region through advocacy and healthcare policy initiatives and regional collaboration amongst its members.

About CanSurive

CanSurvive is the leading patients' advocacy group in Egypt that has been successfully operating for over 7 years. The primary objective of this non-profit organization is to support, empower and help adult cancer patients. For more information, please visit https://www.facebook.com/CanSurvive/ 

References:

[1] EveryVoiceMatters:Egypt (2019); Market research conducted by IPSOS and sponsored by Astellas. Report available on file.

[2] GLOBOCAN.

[3] NHS, Symptoms: Prostate Cancer, 2018. Available at https://www.nhs.uk/conditions/prostate-cancer/symptoms/#. Last accessed September 2019

[4] ProstateCancerUK, Localized prostate cancer, 2019. Available at https://prostatecanceruk.org/prostate-information/just-diagnosed/localised-prostate-cancer. Last accessed September 2019    

SOURCE Astellas Pharma Inc.

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer

Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced they have...

VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses

VYLOY™ (zolbetuximab) Plus Chemotherapy Associated with Enhanced Survival Outcomes when Common Adverse Events are Effectively Managed, According to New Ad Hoc Analyses

Astellas Pharma U.S., Inc. (Head of US Commercial: Mike Petroutsas, "Astellas") today announced the publication of exploratory ad hoc analyses from...

More Releases From This Source

Explore

Biotechnology

Biotechnology

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.